國邦醫藥(605507.SH):已完成工商變更登記並取得換髮營業執照
格隆匯11月11日丨國邦醫藥(605507.SH)公佈,公司於2021年11月3日召開2021年第一次臨時股東大會,審議通過了《關於變更公司經營範圍、修訂<公司章程>並辦理工商變更登記的議案》,對公司經營範圍進行變更,同時修訂《國邦醫藥集團股份有限公司章程》部分條款。近日,公司已完成工商變更登記及公司章程的相關備案登記手續,並取得浙江省市場監督管理局換髮的《營業執照》。經營範圍信息如下:
許可項目:藥品生產;藥品批發;藥品進出口;獸藥生產;獸藥經營;飼料添加劑生產(依法須經批准的項目,經相關部門批准後方可開展經營活動,具體經營項目以審批結果為準)。一般項目:藥品委託生產;飼料添加劑銷售;基礎化學原料製造(不含危險化學品等許可類化學品的製造);化工產品生產(不含許可類化工產品);化工產品銷售(不含許可類化工產品);貨物進出口;技術進出口;進出口代理;貿易經紀;技術服務、技術開發、技術諮詢、技術交流、技術轉讓、技術推廣;企業管理諮詢(除依法須經批准的項目外,憑營業執照依法自主開展經營活動)。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.